Strategic Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Strategic Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2.28M	Sell	20,372 -12,308	-38%	-$1.48M	1.13%	37
2021 Q3	$4.11M	Sell	32,680 -1,225	-4%	-$158K	2.14%	12
2021 Q2	$4.59M	Buy	33,905 +23,246	+218%	+$3.06M	2.48%	13
2021 Q1	$1.45M	Sell	10,659 -2,590	-20%	-$388K	0.87%	39
2020 Q4	$1.86M	Buy	+13,249	New	+$1.7M	1.15%	35

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Strategic Wealth Management's XBI Position: Q4 2021 in Review

Strategic Wealth Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 38% in Q4 2021, selling an estimated $1.48M and leaving 20,372 shares worth $2.28M. The position accounts for 1.13% of the portfolio, ranked #37.

Strategic Wealth Management first reported a position in XBI in Q4 2020 and has held it in 5 quarters since. The position peaked at $4.59M in Q2 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Strategic Wealth Management held 20,372 shares of State Street SPDR S&P Biotech ETF worth $2.28M as of Q4 2021.
Strategic Wealth Management sold 12,308 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $1.48M.
State Street SPDR S&P Biotech ETF made up 1.13% of Strategic Wealth Management's portfolio in Q4 2021, its #37 holding.
Strategic Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 5 quarters since.
Strategic Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $4.59M in Q2 2021.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Strategic Wealth Management's 13F filing for Q4 2021, filed 7 Feb 2022.